Hello,
We have upgraded to cxf 2.7.1 (we had 2.7.0 client side and 2.6.2 server
side)
I am getting these exceptions in the client. On server I get no errors.
The problem goes away when I specify
httpClientPolicy.setAllowChunking(false);
on the client.
Has anybody see this problem? What are the performance implications of
setAllowChunking(false).
Thanks
on Windows
Caused by: org.apache.cxf.transport.http.HTTPException: HTTP response
'408: Request Time-out' when communicating with
http://myhost/MyService:80/ws/MedlineCorpusDBService
at
org.apache.cxf.transport.http.HTTPConduit$WrappedOutputStream.handleResponseInternal(HTTPConduit.java:1528)
at
org.apache.cxf.transport.http.HTTPConduit$WrappedOutputStream.handleResponse(HTTPConduit.java:1488)
at
org.apache.cxf.transport.http.HTTPConduit$WrappedOutputStream.close(HTTPConduit.java:1307)
at org.apache.cxf.transport.AbstractConduit.close(AbstractConduit.java:56)
at org.apache.cxf.transport.http.HTTPConduit.close(HTTPConduit.java:622)
at
org.apache.cxf.interceptor.MessageSenderInterceptor$MessageSenderEndingInterceptor.handleMessage(MessageSenderInterceptor.java:62)
... 16 more
on Linux
org.apache.cxf.interceptor.Fault: Could not send Message.
at
org.apache.cxf.interceptor.MessageSenderInterceptor$MessageSenderEndingInterceptor.handleMessage(MessageSenderInterceptor.java:64)
at
org.apache.cxf.phase.PhaseInterceptorChain.doIntercept(PhaseInterceptorChain.java:271)
at org.apache.cxf.endpoint.ClientImpl.doInvoke(ClientImpl.java:530)
at org.apache.cxf.endpoint.ClientImpl.invoke(ClientImpl.java:463)
at org.apache.cxf.endpoint.ClientImpl.invoke(ClientImpl.java:366)
at org.apache.cxf.endpoint.ClientImpl.invoke(ClientImpl.java:319)
at org.apache.cxf.frontend.ClientProxy.invokeSync(ClientProxy.java:96)
at org.apache.cxf.frontend.ClientProxy.invoke(ClientProxy.java:81)
....
Caused by: java.net.SocketException: SocketException invoking
http://myhost/MyService:80: Unexpected end of file from server
at sun.reflect.NativeConstructorAccessorImpl.newInstance0(Native Method)
at
sun.reflect.NativeConstructorAccessorImpl.newInstance(NativeConstructorAccessorImpl.java:57)
at
sun.reflect.DelegatingConstructorAccessorImpl.newInstance(DelegatingConstructorAccessorImpl.java:45)
at java.lang.reflect.Constructor.newInstance(Constructor.java:525)
at
org.apache.cxf.transport.http.HTTPConduit$WrappedOutputStream.mapException(HTTPConduit.java:1336)
at
org.apache.cxf.transport.http.HTTPConduit$WrappedOutputStream.close(HTTPConduit.java:1320)
at
org.apache.cxf.transport.AbstractConduit.close(AbstractConduit.java:56)
at org.apache.cxf.transport.http.HTTPConduit.close(HTTPConduit.java:622)
at
org.apache.cxf.interceptor.MessageSenderInterceptor$MessageSenderEndingInterceptor.handleMessage(MessageSenderInterceptor.java:62)
... 16 more
Caused by: java.net.SocketException: Unexpected end of file from server
at sun.net.www.http.HttpClient.parseHTTPHeader(HttpClient.java:727)
at sun.net.www.http.HttpClient.parseHTTP(HttpClient.java:589)
at
sun.net.www.protocol.http.HttpURLConnection.getInputStream(HttpURLConnection.java:1319)
at
java.net.HttpURLConnection.getResponseCode(HttpURLConnection.java:468)
at
org.apache.cxf.transport.http.URLConnectionHTTPConduit$URLConnectionWrappedOutputStream.getResponseCode(URLConnectionHTTPConduit.java:248)
at
org.apache.cxf.transport.http.HTTPConduit$WrappedOutputStream.handleResponseInternal(HTTPConduit.java:1515)
at
org.apache.cxf.transport.http.HTTPConduit$WrappedOutputStream.handleResponse(HTTPConduit.java:1488)
at
org.apache.cxf.transport.http.HTTPConduit$WrappedOutputStream.close(HTTPConduit.java:1307)
... 19 more
--
__________________________________
Vassilis Virvilis Ph.D.
Head of IT
Biovista Inc.
US Offices
2421 Ivy Road
Charlottesville, VA 22903
USA
T: +1.434.971.1141
F: +1.434.971.1144
European Offices
34 Rodopoleos Street
Ellinikon, Athens 16777
GREECE
T: +30.210.9629848
F: +30.210.9647606
www.biovista.com
Biovista is a privately held biotechnology company that finds novel uses
for existing drugs, and profiles their side effects using their
mechanism of action. Biovista develops its own pipeline of drugs in CNS,
oncology, auto-immune and rare diseases. Biovista is collaborating with
biopharmaceutical companies on indication expansion and de-risking of
their portfolios and with the FDA on adverse event prediction.
